| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.37 | 0.01 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |